ASPIRE BIOPHARMA ANNOUNCES $21 MILLION PRIVATE PLACEMENT BY SELECT INVESTORS, STRENGTHENING BALANCE SHEET, CAPITAL POSITION, AND FORTIFYING SHAREHOLDER EQUITY TO MEET NASDAQ REQUIREMENTS.
10 February 2026 Proposal for the use of the profit shown on the balance sheet and the payment of dividend. The retained earnings of the Parent Company according to the balance sheet of the Parent...
EmperyDigital Announces Amendment to Debt Facility to Enhance Balance Sheet Flexibility ...Company's balance sheet and support the Company's effort to close the net asset value ("NAV") gap.